Inhibition of myostatin signaling has also been shown to have beneficial metabolic effects in obesity and diabetes, including enhanced glucose tolerance, improved brown adipogenesis, and reduced fat mass.7, 58. The gene discussed is MSTN; the disease is obesity due to melanocortin 4 receptor deficiency.